These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 37726329)
21. Binding of human ACE2 and RBD of Omicron enhanced by unique interaction patterns among SARS-CoV-2 variants of concern. Kim S; Liu Y; Ziarnik M; Seo S; Cao Y; Zhang XF; Im W J Comput Chem; 2023 Feb; 44(4):594-601. PubMed ID: 36398990 [TBL] [Abstract][Full Text] [Related]
22. Computational analysis of affinity dynamics between the variants of SARS-CoV-2 spike protein (RBD) and human ACE-2 receptor. Sultana N; Nagesha SN; Reddy CNL; Ramesh BN; Shyamalamma S; Shashidhara KS; Satish KM; Pradeep C; Vidyadhar GD Virol J; 2024 Apr; 21(1):88. PubMed ID: 38641844 [TBL] [Abstract][Full Text] [Related]
24. Computational design and modeling of nanobodies toward SARS-CoV-2 receptor binding domain. Yang J; Zhang Z; Yang F; Zhang H; Wu H; Zhu F; Xue W Chem Biol Drug Des; 2021 Jul; 98(1):1-18. PubMed ID: 33894099 [TBL] [Abstract][Full Text] [Related]
25. Assessment of mutations on RBD in the Spike protein of SARS-CoV-2 Alpha, Delta and Omicron variants. da Costa CHS; de Freitas CAB; Alves CN; Lameira J Sci Rep; 2022 May; 12(1):8540. PubMed ID: 35595778 [TBL] [Abstract][Full Text] [Related]
26. Dynamics of the interaction between the receptor-binding domain of SARS-CoV-2 Omicron (B.1.1.529) variant and human angiotensin-converting enzyme 2. Antony P; Jobe A; Vijayan R PeerJ; 2022; 10():e13680. PubMed ID: 35811809 [TBL] [Abstract][Full Text] [Related]
27. Effect of Delta and Omicron Mutations on the RBD-SD1 Domain of the Spike Protein in SARS-CoV-2 and the Omicron Mutations on RBD-ACE2 Interface Complex. Ching WY; Adhikari P; Jawad B; Podgornik R Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077490 [TBL] [Abstract][Full Text] [Related]
28. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein. Kumar S; Thambiraja TS; Karuppanan K; Subramaniam G J Med Virol; 2022 Apr; 94(4):1641-1649. PubMed ID: 34914115 [TBL] [Abstract][Full Text] [Related]
29. Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor. Lupala CS; Ye Y; Chen H; Su XD; Liu H Biochem Biophys Res Commun; 2022 Jan; 590():34-41. PubMed ID: 34968782 [TBL] [Abstract][Full Text] [Related]
30. A novel consensus-based computational pipeline for screening of antibody therapeutics for efficacy against SARS-CoV-2 variants of concern including Omicron variant. Kumar N; Kaushik R; Zhang KYJ; Uversky VN; Sahu U; Sood R; Bhatia S Proteins; 2023 Jun; 91(6):798-806. PubMed ID: 36629264 [TBL] [Abstract][Full Text] [Related]
31. Molecular and computational analysis of spike protein of newly emerged omicron variant in comparison to the delta variant of SARS-CoV-2 in Iraq. Rashid PMA; Salih GF Mol Biol Rep; 2022 Aug; 49(8):7437-7445. PubMed ID: 35698014 [TBL] [Abstract][Full Text] [Related]
32. Probing structural basis for enhanced binding of SARS-CoV-2 P.1 variant spike protein with the human ACE2 receptor. Lata S; Akif M J Cell Biochem; 2022 Jul; 123(7):1207-1221. PubMed ID: 35620980 [TBL] [Abstract][Full Text] [Related]
33. A highly sensitive bead-based flow cytometric competitive binding assay to detect SARS-CoV-2 neutralizing antibody activity. Yao X; Zhang Z; Mei Q; Li S; Xing L; Long Y; Zhang D; Wang J; Wang X; Xie B; Yang B; Gao Y; Wu C; Meng Q Front Immunol; 2022; 13():1041860. PubMed ID: 36532082 [TBL] [Abstract][Full Text] [Related]
34. Understanding the Driving Forces That Trigger Mutations in SARS-CoV-2: Mutational Energetics and the Role of Arginine Blockers in COVID-19 Therapy. Ridgway H; Chasapis CT; Kelaidonis K; Ligielli I; Moore GJ; Gadanec LK; Zulli A; Apostolopoulos V; Mavromoustakos T; Matsoukas JM Viruses; 2022 May; 14(5):. PubMed ID: 35632769 [TBL] [Abstract][Full Text] [Related]
35. Identification of Potential ACE2-Derived Peptide Mimetics in SARS-CoV-2 Omicron Variant Therapeutics using Computational Approaches. Paul S; Nadendla S; Sobhia ME J Phys Chem Lett; 2022 Aug; 13(32):7420-7428. PubMed ID: 35929665 [TBL] [Abstract][Full Text] [Related]
37. Computational studies on the interaction of SARS-CoV-2 Omicron SGp RBD with human receptor ACE2, limonin and glycyrrhizic acid. Vardhan S; Sahoo SK Comput Biol Med; 2022 May; 144():105367. PubMed ID: 35247766 [TBL] [Abstract][Full Text] [Related]
38. Equine Anti-SARS-CoV-2 Serum (ECIG) Binds to Mutated RBDs and N Proteins of Variants of Concern and Inhibits the Binding of RBDs to ACE-2 Receptor. Andrade SA; Batalha-Carvalho JV; Curi R; Wen FH; Covas DT; Chudzinski-Tavassi AM; Moro AM Front Immunol; 2022; 13():871874. PubMed ID: 35898497 [TBL] [Abstract][Full Text] [Related]
39. Atomistic insights into the binding of SARS-CoV-2 spike receptor binding domain with the human ACE2 receptor: The importance of residue 493. Carter C; Airas J; Parish CA J Mol Graph Model; 2023 Jan; 118():108360. PubMed ID: 36401897 [TBL] [Abstract][Full Text] [Related]
40. Computer Simulations and Network-Based Profiling of Binding and Allosteric Interactions of SARS-CoV-2 Spike Variant Complexes and the Host Receptor: Dissecting the Mechanistic Effects of the Delta and Omicron Mutations. Verkhivker G; Agajanian S; Kassab R; Krishnan K Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457196 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]